Raiven Capital, a global early-stage venture capital firm, announced today that founding partner Paul Dugsin, will present “Investing in AI from a VC Perspective: Hype, Risk, and Return” at the DDC ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on October 22, 2024, the Compensation Committee of Guardant’s Board of Directors approved the granting of ...